Logo

DxTerity Diagnostics: Brett Swansiger

Feb 04, 2020

DxTerity Diagnostics has appointed Brett Swansiger as chief commercialization officer. Prior to DxTerity, Swansiger held multiple positions at MDxHealth, including VP of managed care and payor strategy. Before MDxHealth, he served as VP of managed care and Asia market acess for Agendia. Prior to Agendia, Swansiger help multiple positions at Prometheus Laboratories. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.